Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2009-7-9
pubmed:abstractText
Circulating tumor cells (CTCs) and [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) are two new promising tools for therapeutic monitoring. In this study, we compared the prognostic value of CTC and FDG-PET/CT monitoring during systemic therapy for metastatic breast cancer (MBC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3303-11
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19451443-Aged, pubmed-meshheading:19451443-Breast Neoplasms, pubmed-meshheading:19451443-Female, pubmed-meshheading:19451443-Fluorodeoxyglucose F18, pubmed-meshheading:19451443-Humans, pubmed-meshheading:19451443-Kaplan-Meier Estimate, pubmed-meshheading:19451443-Middle Aged, pubmed-meshheading:19451443-Multivariate Analysis, pubmed-meshheading:19451443-Neoplasm Metastasis, pubmed-meshheading:19451443-Neoplastic Cells, Circulating, pubmed-meshheading:19451443-Positron-Emission Tomography, pubmed-meshheading:19451443-Prognosis, pubmed-meshheading:19451443-Proportional Hazards Models, pubmed-meshheading:19451443-Retrospective Studies, pubmed-meshheading:19451443-Survival Rate, pubmed-meshheading:19451443-Tomography, X-Ray Computed, pubmed-meshheading:19451443-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
pubmed:affiliation
The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't